Y-mAbs Therapeutics, Inc. Quarterly Other Assets, Current in USD from Q4 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Y-mAbs Therapeutics, Inc. quarterly Other Assets, Current history and growth rate from Q4 2017 to Q2 2024.
  • Y-mAbs Therapeutics, Inc. Other Assets, Current for the quarter ending June 30, 2024 was $2.24M, a 37.2% decline year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.24M -$1.33M -37.2% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $3.48M -$248K -6.65% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $4.96M -$497K -9.12% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 $2.3M -$923K -28.6% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $3.57M -$2.68M -42.9% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $3.73M -$2.37M -38.9% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $5.45M -$2.02M -27% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $3.23M +$426K +15.2% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $6.25M +$2.81M +81.5% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $6.1M +$1.37M +28.9% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $7.47M -$256K -3.31% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $2.8M +$857K +44.1% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $3.45M -$1.82M -34.5% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $4.74M +$674K +16.6% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $7.73M +$2.91M +60.4% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $1.94M +$543K +38.8% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $5.26M +$2.23M +73.8% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $4.06M +$1.3M +47.2% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $4.82M +$1.16M +31.6% Dec 31, 2019 10-K 2021-03-01
Q3 2019 $1.4M -$1.32M -48.6% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $3.03M Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $2.76M Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $3.66M +$2.82M +336% Dec 31, 2018 10-K 2020-03-12
Q3 2018 $2.72M Sep 30, 2018 10-Q 2018-11-13
Q4 2017 $840K Dec 31, 2017 10-K 2019-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.